Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Oct 31, 2019

SELL
$62.98 - $75.72 $251 - $302
-4 Reduced 36.36%
7 $3,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $262 - $335
4 Added 57.14%
11 $7,000
Q4 2016

Sep 10, 2018

BUY
N/A
7
7 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.